@ARTICLE{
author={Popovic Lazar S,Borstnar Simona,Bozovic-Spasojevic Ivana M,Cvetanovic Ana S,Dedic-Plavetic Natalija,Kaneva Radka,Konsoulova Assia,Matos Erika,Tomic Snjezana,Vrdoljak Eduard},
year={2025},
title={Treatment Sequencing in Metastatic HR+/HER2-Breast Cancer: A Delphi Consensus},
journal={CANCERS},
volume={17},
number={9},
pages={-},
document_type={Review},
} 

@ARTICLE{
author={Borstnar Simona,Bozovic-Spasojevic Ivana M,Cvetanovic Ana S,Dedic-Plavetic Natalija,Konsoulova Assia,Matos Erika,Popovic Lazar S,Popovska Savelina,Tomic Snjezana,Vrdoljak Eduard},
year={2024},
title={Advancing HER2-low breast cancer management: enhancing diagnosis and treatment strategies},
journal={RADIOLOGY AND ONCOLOGY},
volume={58},
number={2},
pages={258-267},
document_type={Article},
} 

@ARTICLE{
author={Vrdoljak Eduard,...,Tomasevic Zorica I,...,(broj koautora 16)},
year={2019},
title={Expenditures on Oncology Drugs and Cancer Mortality-to-Incidence Ratio in Central and Eastern Europe},
journal={ONCOLOGIST},
volume={24},
number={1},
pages={E30-E37},
document_type={Article},
} 

@ARTICLE{
author={Kim Tae Won,Elme Anneli,Park Joon Oh,Udrea Anghel Adrian,Kim Sun Young,Ahn Joong Bae,Valencia Ricardo Villalobos,Krishnan Srinivasan,Manojlovic Nebojsa S,Guan Xuesong,Lofton-Day Catherine,Jung A Scott,Vrdoljak Eduard},
year={2018},
title={Final Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer},
journal={CLINICAL COLORECTAL CANCER},
volume={17},
number={3},
pages={206-214},
document_type={Article},
} 

@ARTICLE{
author={Vrdoljak Eduard,...,Tomasevic Zorica I,...,(broj koautora 17)},
year={2016},
title={Cancer Control in Central and Eastern Europe: Current Situation and Recommendations for Improvement},
journal={ONCOLOGIST},
volume={21},
number={10},
pages={1183-1190},
document_type={Article},
}